The antihypertensive mechanism of clonidine in man. Evidence against a generalized reduction of sympathetic activity.
- 1 May 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 3 (3) , 340-346
- https://doi.org/10.1161/01.hyp.3.3.340
Abstract
Recording of multi-unit sympathetic activity were made from muscle branches of the peroneal nerve during i.v. bolus injection of 100 to 275 micrograms clonidine in seven hypertensive patients. Blood pressure was reduced in all patients, but sympathetic activity and heart rate could either increase or decrease. When plasma levels of clonidine were low, sympathetic activity tended to increase, and when plasma levels were high, activity tended to decrease. Irrespective of whether mean level of sympathetic activity increased or decreased with the fall in blood pressure level, transient fluctuations of blood pressure continued to cause dynamic baroreflex modulation of the sympathetic outflow. It is suggested that the drug influences sympathetic outflow by a combination of central and peripheral effects.This publication has 20 references indexed in Scilit:
- Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.British Journal of Clinical Pharmacology, 1978
- Central α-adrenergic systems as targets for hypotensive drugsPublished by Springer Nature ,1978
- Effects of clonidine on the baroreceptor-heart rate reflex and on single aortic baroreceptor fibre dischargeEuropean Journal of Pharmacology, 1974
- Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Effects of clonidine on aortic diameter and aortic baroreceptor activityEuropean Journal of Pharmacology, 1972
- Antihypertensive Effect of ClonidineCirculation Research, 1971
- Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patientsEuropean Journal of Pharmacology, 1970
- Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 115)European Journal of Pharmacology, 1968
- Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)European Journal of Pharmacology, 1967
- ber den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit ImidazolinstrukturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1967